Pharmacy - Drug Approvals News & Articles

161 Effectiveness of FDA’s new over-the-counter acetaminophen warning label in improving consumer risk perception of liver damage Journal of Clinical Pharmacy and Therapeutics, September 10, 2012    Clinical Article

162 U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large Cell Lymphoma Clinical Cancer Research, September 10, 2012    Clinical Article

163 FDA approves new treatment for a type of late-stage prostate cancer Full Text Drug Topics, September 4, 2012    Clinical Article

164 Aspirin- and Clopidogrel-associated Bleeding Complications: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS Full Text International Journal of Medical Sciences , August 31, 2012

165 First Pill for HIV Prevention Approved Full Text U.S. Pharmacist, August 30, 2012    Clinical Article

166 GSK and Theravance announce completion of the Phase III programme for once-daily LAMA/LABA (UMEC/VI) in COPD Full Text GlaxoSmithKline, August 27, 2012

167 FDA warns of seizure risk for multiple sclerosis patients who take dalfampridine Full Text Formulary , August 24, 2012    Clinical Article

168 FDA Approval Summary: Sunitinib for the Treatment of Progressive Well-Differentiated Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors Full Text The Oncologist, August 23, 2012    Clinical Article

169 FDA approves first generic Actos to treat type 2 diabetes Full Text Drug Topics, August 21, 2012

170 Fondaparinux safe in renal impairment Full Text Drug Topics, August 13, 2012    Clinical Article

171 AiCuris Promising Drugs Against Herpes Simplex (AIC316) and Human Cytomegalovirus (Letermovir, AIC246) in Preparation for Phase III B3C newswire, August 8, 2012

172 Effect of Fixed-Dose Combined Isosorbide Dinitrate/Hydralazine in Elderly Patients in the African-American Heart Failure Trial Journal of Cardiac Failure, August 7, 2012    Clinical Article

173 New developments in the management of hepatitis C virus infection: focus on boceprevir Full Text Biologics: targets & therapy, August 6, 2012    Clinical Article

174 Abbott's humira (adalimumab) approved in europe for treatment of non-radiographic axial spondyloarthritis (nr-axspa) Abbott, July 31, 2012

175 Medtronic announces 510(k) clearance of bipolar sealer with cutting for orthopaedic surgery Full Text Medtronic, July 31, 2012

176 Novartis drug Afinitor approved by European Commission to treat patients with the most common form of advanced breast cancer Full Text Novartis, July 31, 2012

177 Covidien announces fda 510(k) clearance of the nellcor bedside spo2 patient monitoring system Covidien, July 31, 2012

178 At-home HIV test backed by FDA panel Full Text U.S. Pharmacist, July 30, 2012

179 FDA clears Roche's vitamin D laboratory test Full Text Roche, July 27, 2012

180 FDA advisory committee unanimously recommends approval of lucentis for treatment of diabetic macular edema (dme) Full Text Genentech, July 27, 2012

1 Phentermine and topiramate for the management of obesity: a review Drug Design, Development and Therapy, April 12, 2013    Free full text    Review Article

2 Clostridium Difficile Colitis: Review of the Therapeutic Approach American Journal of Therapeutics, April 8, 2013

3 FDA approves three new drug treatments for type 2 diabetes FDA Press Announcements, January 29, 2013    Free full text

4 Tadalafil: A Phosphodiesterase-5 Inhibitor for Benign Prostatic Hyperplasia Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, April 2, 2013

5 Unapproved Drugs--The Drug Information Pharmacists Perspective Journal of Pharmacy Practice, March 29, 2013    Review Article

6 Ceftaroline - a cause for neutropenia Journal of Clinical Pharmacy and Therapeutics, April 22, 2013

7 Novartis receives EU approval for Ilaris in patients suffering acute gouty arthritis attacks who cannot gain relief from current treatments Novartis, March 4, 2013    Free full text

8 FDA approves new multiple sclerosis treatment: Tecfidera FDA Press Announcements, April 1, 2013    Free full text

9 Benefits and Risks of Daily Aspirin Use U.S. Pharmacist, February 27, 2013    Free full text

10 Actemra, a Treatment for Rheumatoid Arthritis Obtained Approval for Subcutaneous Injection Formulation Chugai Pharmaceutical Co., March 26, 2013    Free full text

11 Merck Announces Breakthrough Therapy Designation for Lambrolizumab an Investigational Antibody Therapy for Advanced Melanoma Merck, April 29, 2013    Free full text

12 Sarepta Therapeutics Announces FDA Will Consider Accelerated Approval for Eteplirsen After Further Review of Data on Dystrophin and Clinical Outcomes Sarepta Therapeutics, April 19, 2013    Free full text

13 FDA Advisory Committee Recommends Approval for Boehringer Ingelheims Olodaterol* for Maintenance Treatment of COPD Boehringer Ingelheim, January 31, 2013    Free full text

14 FDA Lists Guidance Documents Planned for 2013 BioPharm International, February 11, 2013    Free full text

15 Apixaban: Third oral anticoagulant to compete with warfarin American Pharmacists Association News, March 14, 2013    Free full text

16 Pomalidomide: Thalidomide analogue for multiple myeloma American Pharmacists Association News, April 5, 2013    Free full text

17 FDA approves abuse-deterrent labeling for reformulated OxyContin FDA Press Announcements, April 18, 2013    Free full text

18 FDA approves first Botulism Antitoxin for use in neutralizing all seven known botulinum nerve toxin serotypes FDA Press Announcements, March 25, 2013    Free full text

19 Quality-improvement analytics for intravenous infusion pumps American Journal of Health-System Pharmacy, April 11, 2013

20 Targeting kinases: a new approach to treating inflammatory rheumatic diseases Current Opinion in Pharmacology , March 22, 2013    Review Article